✦ LIBER ✦

Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial

✍ Scribed by Lynn G. Feun; Christopher O'Brien; Enrique Molina; Miguel Rodriguez; Lenox Jeffers; Eugene R. Schiff; Angela Marini; Niramol Savaraj; Bach Ardalan

Book ID: 106123222
Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 170 KB
Volume: 129
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-002-0398-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant leukocyte a interferon with

Recombinant leukocyte a interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma

✍ E. T. Creagan; H. J. Long; S. Frytak; C. G. Moertel 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

A phase I-II trial of the combination of

A phase I-II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon-γ in patients with metastatic malignant melanoma

✍ Edward T. Creagan; Charles L. Loprinzi; David L. Ahmann; Daniel J. Schaid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

Phase II study of doxorubicin and cispla

Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma

✍ Jeeyun Lee; Joon Oh Park; Won Seog Kim; Se Hoon Park; Keon Woo Park; Moon Seok C 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 205 KB

A phase II trial of oral eniluracil/5-fl

A phase II trial of oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma

✍ J.M Llovet; P Ruff; N Tassopoulos; L Castells; J Bruix; I El-Hariry; M Peachey 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A phase II trial of gemcitabine in patie

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili

A phase II and pharmacokinetic study of

A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

✍ Ruey-Long Hong; Yun-Long Tseng 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 200 KB